Seizure activity and unresponsiveness after hydroxycut ingestion
A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut i...
Saved in:
Published in | Pharmacotherapy Vol. 21; no. 5; p. 647 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2001
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut is a dietary supplement purported to be energy enhancing, muscle building, and fat burning. The agent contains ephedra alkaloids and caffeine, which are both central nervous system stimulants; the etiology of seizure was attributed to their consumption. Due to a significant number of reported adverse events, the United States Food and Drug Administration (FDA) proposed regulations for dietary supplements containing ephedra alkaloids and requested an independent review of case reports linked to these products. Because herbal products are not subject to the same rigorous FDA regulations required for prescription and over-the-counter products, consumers unknowingly risk adverse effects when taking these products. Questioning patients about consumption of herbal products should be part of routine medical visits. |
---|---|
AbstractList | A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates, acetaminophen, alcohol, and drugs of abuse. Medical history was insignificant with the exception of recent (within 2 wks) ingestion of Hydroxycut is a dietary supplement purported to be energy enhancing, muscle building, and fat burning. The agent contains ephedra alkaloids and caffeine, which are both central nervous system stimulants; the etiology of seizure was attributed to their consumption. Due to a significant number of reported adverse events, the United States Food and Drug Administration (FDA) proposed regulations for dietary supplements containing ephedra alkaloids and requested an independent review of case reports linked to these products. Because herbal products are not subject to the same rigorous FDA regulations required for prescription and over-the-counter products, consumers unknowingly risk adverse effects when taking these products. Questioning patients about consumption of herbal products should be part of routine medical visits. |
Author | McCarthy, M W Kockler, D R Lawson, C L |
Author_xml | – sequence: 1 givenname: D R surname: Kockler fullname: Kockler, D R organization: Department of Pharmacy Services, Drug Information Center, University of Virginia Health System, Charlottesville 22908-0674, USA – sequence: 2 givenname: M W surname: McCarthy fullname: McCarthy, M W – sequence: 3 givenname: C L surname: Lawson fullname: Lawson, C L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11349754$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tKAzEUQLOo2Id-gSD5gRnzzmSnFF9QcNG6LpnkxkZsZkhmiuPXK6icxdkdOEs0S10ChK4oqak07KY_uK5mtFa1ErrmQgo2QwvCtK4IIc0cLUt5J4RRJdg5mlPKhdFSLNDtFuLXmAFbN8RTHCZsk8djylD6LpV4ggSlYBsGyPgw-dx9Tm4ccExvUIbYpQt0FuxHgcs_r9Drw_1u_VRtXh6f13ebynHd6Mow7k1jXAhO2tYq4IoLp6TjtqFMt1wCdZ6BheDED84r1dJWKSOUBR7YCl3_dvuxPYLf9zkebZ72_yvsG4-XTno |
CitedBy_id | crossref_primary_10_1081_CLT_58946 crossref_primary_10_1007_s00210_019_01786_0 crossref_primary_10_1089_jcr_2012_0021 crossref_primary_10_1081_CLT_44771 crossref_primary_10_2165_00128415_200108600_00019 crossref_primary_10_1211_fact_2001_00309 crossref_primary_10_1016_j_jand_2016_02_015 crossref_primary_10_1176_appi_psy_44_6_508 crossref_primary_10_1213_01_ane_0000246444_65298_54 crossref_primary_10_2146_ajhp050270 crossref_primary_10_1136_bcr_2012_007509 crossref_primary_10_2146_ajhp070640 crossref_primary_10_4253_wjge_v5_i4_180 crossref_primary_10_1007_s12245_009_0105_z crossref_primary_10_1093_jn_131_12_3319 crossref_primary_10_3810_psm_2003_12_592 crossref_primary_10_1097_00042752_200207000_00003 crossref_primary_10_1016_j_emc_2005_03_011 crossref_primary_10_1016_j_toxlet_2003_07_006 crossref_primary_10_1016_j_fct_2016_07_001 crossref_primary_10_1016_j_clinthera_2014_08_012 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1592/phco.21.6.647.34542 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 11349754 |
Genre | Journal Article Case Reports |
GroupedDBID | --- .GJ .Y3 05W 0R~ 0VX 123 1CY 1OB 1OC 31~ 33P 34G 39C 3SF 4.4 50Z 52U 52V 53G 5RE 8-0 8-1 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AAQQT AASGY AAXRX AAYCA AAYOK AAZKR ABCUV ABJNI ABLJU ABOCM ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BRXPI CGR CS3 CUY CVF DCZOG DPXWK DRFUL DRMAN DRSTM DU5 EBD EBS ECM EIF EJD EMOBN F5P FEDTE FUBAC G-S GODZA GWYGA H.X HGLYW HVGLF HZ~ J5H KBYEO LATKE LEEKS LH4 LITHE LOXES LSO LUTES LW6 LYRES MEWTI MJL MK0 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ NPM O66 O9- P2P P2W PALCI PQQKQ Q.N QB0 R.K RIWAO RJQFR ROL SAMSI SJN SUPJJ SV3 TUS TWZ UDS WBKPD WHWMO WIH WIJ WIK WOHZO WVDHM WXSBR YCJ ZGI ZXP ZZTAW ~WT |
ID | FETCH-LOGICAL-c3787-923d989cffc5aba6e3634c65c3a8127b35e1cd2eaefc4c4ccd66b1b66946ae3f2 |
ISSN | 0277-0008 |
IngestDate | Wed Feb 19 01:26:33 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3787-923d989cffc5aba6e3634c65c3a8127b35e1cd2eaefc4c4ccd66b1b66946ae3f2 |
PMID | 11349754 |
ParticipantIDs | pubmed_primary_11349754 |
PublicationCentury | 2000 |
PublicationDate | May 2001 |
PublicationDateYYYYMMDD | 2001-05-01 |
PublicationDate_xml | – month: 05 year: 2001 text: May 2001 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Pharmacotherapy |
PublicationTitleAlternate | Pharmacotherapy |
PublicationYear | 2001 |
SSID | ssj0021642 |
Score | 1.7446661 |
Snippet | A 22-year-old man was hospitalized after unexplained seizure-like activity and unresponsiveness. A urine toxicology screen was negative for salicylates,... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 647 |
SubjectTerms | Adult Caffeine - adverse effects Central Nervous System Stimulants - adverse effects Citrates - adverse effects Drug Combinations Drugs, Chinese Herbal - adverse effects Ephedra sinica Ephedrine - adverse effects Humans Male Phytotherapy Picolinic Acids - adverse effects Plant Preparations Polysaccharides - adverse effects Seizures - chemically induced Seizures - psychology Theobromine - adverse effects Theophylline - adverse effects |
Title | Seizure activity and unresponsiveness after hydroxycut ingestion |
URI | https://www.ncbi.nlm.nih.gov/pubmed/11349754 |
Volume | 21 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYKXPaCeC1v5APiAsk2cew2NxAPIaAIiSJxQ_bEUTnQVqIcyq9nxnGaUGAFKFIU2VHk5JuM5uH5hrHdphYQi6QVNNuQBkmmTaBt2wRoHcSG-NfbTaod7lyr87vk4l7eNxqH9eqSkQnh9dO6kt-gimOIK1XJ_gDZyUNxAK8RXzwjwnj-Fsa39vHVJQDA94CgKPgLEfi4fa9ejxVtwHvjjHaswAv1BKCkUgmIt0xvPIf16D3NwOWAcr8O1pNqc2EHjnE5BUCd_UmY5sqlYF3s1VczlPGEqNq959UOJXXJNKjryDiqyYKsKTxV8GV-UMQyJWLXYQ8GYRyFKsT7QpHIgkmrBs3wyWETEUtiq6CT_v_sFDt2OTXDZtBPoManFK3xDje6gi6LVL6RZ53Ctf37ZGXEH-ufNuVjOFuju8DmvZPAjwrEF1nD9pfYnkdofMC7VdHc8wHf4zcV__h4mR16seClWHAUCz4tFtyJBa_Egk_EYoXdnZ12j88D3ygjAIEKN0AjPUvbKeQ5SG20skKJBJQEodF-axkhbQRZbLXNIcEDMqVMZJRKE6WtyOO_bLY_6Ns1xpu5TA0Apb_TJMti4rtTOjO5laAjDetstfgyD8OCDeWh_GYbX85ssj-VoG2xuRx_P7uNttzI7DjA3gCb4Ujw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seizure+activity+and+unresponsiveness+after+hydroxycut+ingestion&rft.jtitle=Pharmacotherapy&rft.au=Kockler%2C+D+R&rft.au=McCarthy%2C+M+W&rft.au=Lawson%2C+C+L&rft.date=2001-05-01&rft.issn=0277-0008&rft.volume=21&rft.issue=5&rft.spage=647&rft_id=info:doi/10.1592%2Fphco.21.6.647.34542&rft_id=info%3Apmid%2F11349754&rft_id=info%3Apmid%2F11349754&rft.externalDocID=11349754 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-0008&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-0008&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-0008&client=summon |